Table 3.

Results of the analysis of the prognostic factors for overall survival.

	Univariate analysis		Multivariate analysis
	HR (95% CI)	P value	HR (95% CI)	P value
SII		<0.001		<0.001
Low	1.00		1.00
High	4.296 (2.906 -6.350)		3.825 (2.594 -5.640)
Patient age		0.745
≤ 40	1.00
>40	0.927 (0.589 -1.460)
ER		0.187
–	1.00
+	0.774 (0.528 -1.133)
PR		0.517
–	1.00
+	0.883 (0.605 -1.288)
HER2		0.733
–	1.00
+	0.916 (0.552 -1.519)
Ki-67 status		0.112
–	1.00
+	1.636 (0.892 -3.000)
pT Stage		0.003		<0.001
1	1.00		1.00
2-4	1.300 (1.093 -1.546)		1.377 (1.162 -1.632)
pN Stage		0.006		0.035
–	1.00		1.00
+	1.272 (1.070 -1.512)		1.211 (1.014 -1.447)
Histological grade		<0.001		0.006
I-II	1.00		1.00
III	2.058 (1.364-3.101)		1.937 (1.207 -3.106)
Surgery type		0.569
Mastectomy	1.00
BCS	1.147 (0.721-1.820)
Chemotherapy		0.151
Yes	1.00
No	0.752 (0.508-1.109)
Radiotherapy		0.533
Yes	1.00
No	0.885 (0.598-1.305)
Hormonal therapy		0.212
No	1.00
Yes	0.779 (0.525-1.153)
Target therapy		0.405
No	1.00
Yes	1.223 (0.764-1.959)